Cerecor Inc (CERC) Director Acquires $49,338.90 in Stock

Cerecor Inc (NASDAQ:CERC) Director Armistice Capital, Llc bought 12,651 shares of the business’s stock in a transaction that occurred on Friday, January 11th. The shares were bought at an average price of $3.90 per share, with a total value of $49,338.90. The purchase was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this link.

Armistice Capital, Llc also recently made the following trade(s):

  • On Wednesday, January 9th, Armistice Capital, Llc bought 545 shares of Cerecor stock. The shares were bought at an average price of $3.79 per share, with a total value of $2,065.55.
  • On Monday, January 7th, Armistice Capital, Llc bought 6,504 shares of Cerecor stock. The shares were bought at an average price of $3.65 per share, with a total value of $23,739.60.
  • On Friday, January 4th, Armistice Capital, Llc bought 20,000 shares of Cerecor stock. The shares were bought at an average price of $3.42 per share, with a total value of $68,400.00.
  • On Tuesday, December 31st, Armistice Capital, Llc bought 12,300 shares of Cerecor stock. The shares were bought at an average price of $3.18 per share, with a total value of $39,114.00.
  • On Saturday, December 28th, Armistice Capital, Llc bought 26,499 shares of Cerecor stock. The shares were bought at an average price of $3.12 per share, with a total value of $82,676.88.
  • On Monday, December 31st, Armistice Capital, Llc bought 12,300 shares of Cerecor stock. The shares were bought at an average price of $3.18 per share, with a total value of $39,114.00.
  • On Friday, December 28th, Armistice Capital, Llc acquired 26,499 shares of Cerecor stock. The stock was acquired at an average price of $3.12 per share, with a total value of $82,676.88.
  • On Monday, December 17th, Armistice Capital, Llc acquired 14,938 shares of Cerecor stock. The stock was acquired at an average price of $3.26 per share, with a total value of $48,697.88.
  • On Friday, December 14th, Armistice Capital, Llc acquired 28,032 shares of Cerecor stock. The stock was acquired at an average price of $3.33 per share, with a total value of $93,346.56.
  • On Monday, December 10th, Armistice Capital, Llc acquired 13,815 shares of Cerecor stock. The stock was acquired at an average price of $3.36 per share, with a total value of $46,418.40.

Shares of NASDAQ:CERC opened at $3.90 on Monday. Cerecor Inc has a 12 month low of $2.36 and a 12 month high of $5.74. The company has a debt-to-equity ratio of 0.74, a quick ratio of 0.70 and a current ratio of 0.74. The stock has a market cap of $154.25 million, a price-to-earnings ratio of 9.29 and a beta of 1.30.

Cerecor (NASDAQ:CERC) last issued its quarterly earnings data on Tuesday, November 13th. The company reported ($0.26) EPS for the quarter, missing analysts’ consensus estimates of ($0.12) by ($0.14). Cerecor had a negative return on equity of 75.94% and a negative net margin of 241.29%. The company had revenue of $4.08 million for the quarter, compared to the consensus estimate of $4.80 million. Analysts expect that Cerecor Inc will post -1.09 earnings per share for the current fiscal year.

A number of equities analysts have recently issued reports on CERC shares. LADENBURG THALM/SH SH initiated coverage on shares of Cerecor in a research note on Thursday, December 20th. They issued a “buy” rating and a $9.00 price objective for the company. ValuEngine raised shares of Cerecor from a “hold” rating to a “buy” rating in a report on Thursday, November 1st. Finally, TheStreet raised shares of Cerecor from a “d” rating to a “c” rating in a report on Monday, November 12th.

A number of large investors have recently modified their holdings of CERC. Cambridge Investment Research Advisors Inc. bought a new stake in Cerecor during the 3rd quarter worth about $169,000. BlackRock Inc. grew its holdings in Cerecor by 630.4% during the 2nd quarter. BlackRock Inc. now owns 27,520 shares of the company’s stock worth $120,000 after acquiring an additional 23,752 shares during the last quarter. Finally, Vanguard Group Inc grew its holdings in Cerecor by 10.1% during the 3rd quarter. Vanguard Group Inc now owns 87,929 shares of the company’s stock worth $411,000 after acquiring an additional 8,094 shares during the last quarter. 44.48% of the stock is currently owned by hedge funds and other institutional investors.

COPYRIGHT VIOLATION NOTICE: “Cerecor Inc (CERC) Director Acquires $49,338.90 in Stock” was originally reported by The Lincolnian Online and is the sole property of of The Lincolnian Online. If you are reading this report on another site, it was illegally copied and republished in violation of US & international copyright legislation. The correct version of this report can be viewed at https://www.thelincolnianonline.com/2019/01/14/cerecor-inc-cerc-director-acquires-49338-90-in-stock.html.

About Cerecor

Cerecor Inc, a pharmaceutical company, focuses on pediatric health care. Its lead product portfolio includes prescribed dietary supplements, such as Poly-Vi-Flor and Tri-Vi-Flor; and prescription drugs, such as Millipre, Veripred, and Ulesfia for the treatment of inflammation of the skin, joints, lungs, and other organs, as well as asthma, allergies, arthritis, and head lice infestation.

Further Reading: How to interpret a stock’s beta number

Insider Buying and Selling by Quarter for Cerecor (NASDAQ:CERC)

Receive News & Ratings for Cerecor Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cerecor and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply